334 related articles for article (PubMed ID: 27993289)
1. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
Li JX; Fan LC; Li MH; Cao WJ; Xu JF
Respir Med; 2017 Jan; 122():33-42. PubMed ID: 27993289
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases.
Aydın Ö; Sözener ZÇ; Soyyiğit Ş; Kendirlinan R; Gençtürk Z; Mısırlıgil Z; Mungan D; Sin BA; Demirel YS; Çelik GE; Bavbek S
Allergy Asthma Proc; 2015; 36(6):493-500. PubMed ID: 26534756
[TBL] [Abstract][Full Text] [Related]
5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
[TBL] [Abstract][Full Text] [Related]
6. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
[TBL] [Abstract][Full Text] [Related]
7. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
[TBL] [Abstract][Full Text] [Related]
8. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
[TBL] [Abstract][Full Text] [Related]
9. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis.
Cunha FSD; Valle SOR; Elabras Filho J; Dortas Júnior SD; França AT
J Bras Pneumol; 2018; 44(5):439-441. PubMed ID: 30517345
[No Abstract] [Full Text] [Related]
11. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
Tanou K; Zintzaras E; Kaditis AG
Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
[TBL] [Abstract][Full Text] [Related]
13. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
Lin RY; Sethi S; Bhargave GA
J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Omalizumab in Patients with Allergic Bronchopulmonary Aspergillosis Complicated by Chronic Bacterial Infection in the Airways.
Tomomatsu K; Oguma T; Baba T; Toyoshima M; Komase Y; Taniguchi M; Asano K;
Int Arch Allergy Immunol; 2020; 181(7):499-506. PubMed ID: 32388510
[TBL] [Abstract][Full Text] [Related]
15. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
Moss RB
Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review.
Cai C; Qu J; Zhou J
BMC Pulm Med; 2023 Oct; 23(1):389. PubMed ID: 37833657
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A; Corriveau S; Sykes J; Coriati A; Cortes D; Vadas P; Chaparro C; McIntyre K; Tullis E; Stephenson AL
J Cyst Fibros; 2020 Jan; 19(1):119-124. PubMed ID: 31405730
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
[No Abstract] [Full Text] [Related]
19. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
Emiralioglu N; Dogru D; Tugcu GD; Yalcin E; Kiper N; Ozcelik U
Ann Pharmacother; 2016 Mar; 50(3):188-93. PubMed ID: 26699090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]